
CLBT Stock Forecast & Price Target
CLBT Analyst Ratings
Bulls say
Cellebrite DI is facing some near-term headwinds due to longer sales cycles and lower expansion from Inseyets conversions, resulting in a slower projected growth rate for CY27. However, they have taken appropriate steps to address these challenges and are expected to see continued growth in CY27, with a projected increase in EBITDA. Additionally, their solutions may face perceived privacy and human rights concerns, but they have established a strong customer base and plan to continue introducing new solutions to cross-sell and upsell existing customers. Overall, the company appears undervalued compared to its peers and continues to see growth with new product offerings.
Bears say
Cellebrite DI is facing near-term headwinds due to push-outs on a handful of large deals and lower than expected contribution from product upgrades. However, with a new CEO in place, new product launches and a strong customer base, the company is poised to accelerate growth in the future. Its dependence on government and law enforcement agencies for revenue, competition in the market, and currency fluctuations are potential risks but the company's purpose-built DI platform and strong customer relationships help reduce these risks. Despite recent setbacks, the company has strong fundamentals with 30%+ Free Cash Flow Margins and an attractive valuation compared to its peers, leading to a long-term buy recommendation.
This aggregate rating is based on analysts' research of Cellebrite DI Ltd and is not a guaranteed prediction by Public.com or investment advice.
CLBT Analyst Forecast & Price Prediction
Start investing in CLBT
Order type
Buy in
Order amount
Est. shares
0 shares